Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Xcode Life Announces the South Asian Genome (SAGE) Project


CHENNAI, India, June 23, 2018 /PRNewswire/ -- Xcode Life, an innovative personal genomics company has announced the worldwide launch of the South Asian Genome (SAGE) Project. This is open to all individuals with known South Asian roots.

All individuals who qualify the eligibility criteria will receive an Xcode Origin ancestry report worth $40 free of cost. The project is open to individuals who have their raw data from ancestry genetic testing companies like 23andMe, Ancestry DNA, Family Tree DNA, Living DNA, My Heritage DNA.

Xcode Life was founded in 2011 and is the only major genomics company that provides a detailed breakup of the South Asian ancestry composition alongside the global composition. With an extensive South Asian customer base, Xcode Life covers populations that are otherwise left out in the ancestry composition analysis by other companies. The goal of this project is to expand the South Asian ethnic groups represented in Xcode's Origin ancestry composition report, from the current count of 35 to more than 50.

Xcode Life is well known for its large and diversified portfolio of genetic reports it offers based on data from almost all global ancestry DNA data providers, including 23andMe, Ancestry DNA, Family Tree DNA, MyHeritage DNA and Living DNA. Xcode's current product portfolio includes Ancestry, Nutrition, Fitness, Health, Precision Medicine, MTHFR among others.

To know your eligibility to participate in SAGE, visit the official page for the project.

For details contact: James, [email protected]

Related Links

SAGE Project

SOURCE Xcode Life


These press releases may also interest you

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: